Icotinib hydrochloride clinical trials
Also written Conmana.
A product of Icotinib; its studies count on that page too.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses icotinib hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 3
Betta Pharmaceuticals Co., Ltd. (3) · Yuhong Li (1) · Henan Provincial People's Hospital (1) · Roswell Park Cancer Institute (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Icotinib
- One of Protein Kinase Inhibitors source
- One of Tyrosine kinase inhibitors (TKIs) source
Studies
Open first, then newest update. How each study uses icotinib hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional ChemotherapyCompletedPhase 2Yuhong LiNCT01973725Written as Icotinib HydrochlorideHow we know
- Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisTerminatedPhase 2Betta Pharmaceuticals Co., Ltd.NCT03222622Written as Icotinib hydrochloride creamHow we know
- Icotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisCompletedPhase 1Betta Pharmaceuticals Co., Ltd.NCT02801435Written as 0.5% Icotinib hydrochloride creamHow we know
- Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis PatientsCompletedPhase 1Betta Pharmaceuticals Co., Ltd.NCT02574091Written as 1% icotinib hydrochloride creamHow we know
- Conmana Combined With Thalidomide to Treat NSCLCStatus unknownPhase 4Henan Provincial People's HospitalNCT02778893Written as ConmanaHow we know
- Icotinib Hydrochloride in Treating Patients With Advanced CancersWithdrawnPhase 1Roswell Park Cancer InstituteNCT02033148Written as icotinib hydrochlorideHow we know
As the comparator · 2 — what is tested is compared with icotinib hydrochloride
- D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLCCompletedPhase 2/3Betta Pharmaceuticals Co., Ltd.NCT04206072Written as Icotinib Hydrochloride TabletsHow we know
- Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFRStatus unknownPhase 2Tianjin Medical University Cancer Institute and HospitalNCT01744925Written as Icotinib of routine doseHow we know
Codes
What other systems call icotinib hydrochloride · ClinicalTrials.gg INT016980
- UNII (FDA) JTD32I0J83ICOTINIB HYDROCHLORIDEConfirmed FDA, Wikidata
- Wikidata Q27281690icotinib hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C99160Icotinib HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | JTD32I0J83 | ICOTINIB HYDROCHLORIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27281690 | icotinib hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C99160 | Icotinib Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.